94 publications
Name | Date | Type | Actions |
---|---|---|---|
Monthly information regarding the total number of voting rights ans shares making of the share capital - november As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
08/12/2022 | Voting rights | |
Buyback programs - november 2022 Monthly communication regarding buyback programs |
08/12/2022 | Description of buyback programs | |
Monthly communication regarding buyback programs - october 2022 |
10/11/2022 | Voting rights | |
Buyback programs - october 2022 Monthly communication regarding buyback programs |
10/11/2022 | Description of buyback programs | |
First nine months 2022 sales: €405M In line with year-end outlook |
12/10/2022 | Public releases | |
Monthly communication regarding buyback programs - September 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
05/10/2022 | Voting rights | |
Buyback programs - september 2022 Monthly communication regarding buyback programs |
05/10/2022 | Description of buyback programs | |
2022 HALF YEAR RESULTS Additional information on the Group’s strategy Following the conference call organised on 15 September 2022 to present its half-year results, Vetoquinol would like to provide some additional information on the strategy implemented and its outlook. |
23/09/2022 | Public releases , Half Year Report | |
2022 half-year results This document has been prepared by Vetoquinol for the sole purpose of presenting the half-year results for the fiscal year 2022, on September 15, 2022. |
15/09/2022 | Half Year Report | |
2022 HALF YEAR RESULTS Sales: €271m (up 6.0% as reported) |
15/09/2022 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - August 2022 As per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
06/09/2022 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - July 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
22/08/2022 | Voting rights | |
H1 2022 Sales H1 2022 Sales: €271m, up 6.1% |
20/07/2022 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - june 2022 as per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
05/07/2022 | Voting rights | |
Buyback programs - may 2022 Monthly communication regarding buyback programs |
03/06/2022 | Monthly communication regarding buyback programs | |
Monthly information regarding the total number of voting rights and shares making of the share capital - may 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
03/06/2022 | Voting rights | |
Remuneration vote results - AG may 2022 |
20/05/2022 | Shareholders´s Meeting | |
Vote results - AG may 19, 2022 |
20/05/2022 | Shareholders´s Meeting | |
Information regarding the total number of voting rights and shares making of the share capital - 12 may 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
13/05/2022 | Shareholders´s Meeting | |
Monthly information regarding the total number of voting rights and shares making of the share capital - april 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
05/05/2022 | Voting rights | |
Buyback programs - april 2022 Monthly communication regarding buyback programs |
05/05/2022 | Monthly communication regarding buyback programs | |
Universal registration document 2021 Universal Registration Document including the Annual Financial Report |
05/05/2022 | Reference document | |
Balo new information Balo new information |
05/05/2022 | Shareholders´s Meeting | |
Number of voting rights and shares making of the share capital Information regarding the total number of voting rights and shares making of the share capital - J-21 before AGM as per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
03/05/2022 | Shareholders´s Meeting | |
Annual general meeting 2022 - brochure |
28/04/2022 | Shareholders´s Meeting | |
Availability of the 2021 universal registration document Vetoquinol informs that it has filed its 2021 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 22th, 2022. |
22/04/2022 | Public releases | |
Vote by post / proxy form Vote by post of proxy form for annual general meeting on May 19, 2022 |
19/04/2022 | Shareholders´s Meeting | |
General annual meeting - may 19 2022 Annual General Meeting on May 19, 2022 - convocation |
19/04/2022 | Shareholders´s Meeting | |
Q1 2022 SALES: €135M Q1 2022 SALES: €135M |
13/04/2022 | Public releases | |
Buyback programs - march 2022 Monthly communication regarding buyback programs |
06/04/2022 | Monthly communication regarding buyback programs | |
Monthly information regarding the total number of voting rights and shares - march 2022 Monthly information regarding the total number of voting rights and shares making of the share capital as per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
06/04/2022 | Voting rights | |
2021 Annual results ALL FINANCIAL INDICATORS UP. |
24/03/2022 | Public releases | |
Annual results 2021 (slideshow) This document was prepared by Vetoquinol for the sole purpose of presenting the annual results for the year 2021 on March 24, 2022. |
24/03/2022 | Annual Report | |
[AUDIO] Présentation des résultats 2021 Présentation analystes & investisseurs - 24 mars 2022 |
24/03/2022 | Annual Report | |
Monthly information regarding the total number of voting rights and shares making of the share capital- february 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
04/03/2022 | Voting rights | |
Buyback programs - february 2022 Buyback programs - February 2022 |
04/03/2022 | Monthly communication regarding buyback programs | |
Buyback programs - January 2022 |
07/02/2022 | Monthly communication regarding buyback programs | |
Double-digit growth in 2021 Total Group Sales: €521 million (up 21.9% as reported) |
20/01/2022 | Public releases | |
Clone of Monthly information regarding the total number of voting rights and shares making of the share capital As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
06/01/2022 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
06/01/2022 | Voting rights | |
Programme de rachat - Décembre 2021 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres. |
04/01/2022 | Monthly communication regarding buyback programs | |
Bilan annuel des moyens alloués au contrat de liquidité (décembre 2021) Au titre du contrat de liquidité confié par la Société VETOQUINOL à la Société ODDO CORPORATE FINANCE, les moyens suivants figuraient au compte de liquidité au 31 décembre 2021 |
04/01/2022 | Liquidity contract | |
Vétoquinol markets CEFTIOCYL® and KEFLORIL® two new injectable antibiotics for livestock Lure, December 15, 2010 – In line with recent announcements, Vétoquinol is |
15/12/2010 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - November 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
07/12/2010 | Voting rights | |
Programme de rachat - novembre 2010(french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
07/12/2010 | Monthly communication regarding buyback programs | |
November 30, 2010 (Lure, France) – Vétoquinol has appointed Régis Vimal du Monteil as |
30/11/2010 | Public releases | |
Vétoquinol registers its injectable Marbocyl® 2% and Marbocyl® 10% antibiotics in Japan November 18, 2010 (Lure, France) – Vétoquinol has just obtained Marketing |
18/11/2010 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - October2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
10/11/2010 | Voting rights | |
Programme de rachat - octobre 2010(french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
10/11/2010 | Monthly communication regarding buyback programs | |
Strong Sales in the 3rd Quarter of 2010 Vétoquinol’s revenues for the third quarter of 2010 rose by 10.8%. This healthy rate of growth was attributable mainly to strong performance in the Group’s strategic regions and therapeutic segments. |
19/10/2010 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - September 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
08/10/2010 | Voting rights | |
Programme de rachat - septembre 2010(french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
08/10/2010 | Monthly communication regarding buyback programs | |
Mise à disposition ou de consultation du rapport financier semestriel 2010 (french) Le Rapport financier semestriel 2010 de Vétoquinol peut être consulté ou téléchargé sur |
17/09/2010 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - August 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
06/09/2010 | Voting rights | |
Programme de rachat - août 2010(french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
06/09/2010 | Monthly communication regarding buyback programs | |
Rapport financier semestriel 2010 (french) 1. Rapport d’activité semestriel 2010 |
01/09/2010 | Half Year Report | |
Vétoquinol: H1 2009 interim earnings 1.‘Hybrid’ growth |
31/08/2010 | Half Year Report | |
Strong Results in the first half of 2010 The Board of Directors of Vétoquinol, meeting on August 30, reviewed the group’s business and approved its interim 2010 financial statements. |
30/08/2010 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - July 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
17/08/2010 | Voting rights | |
Programme de rachat - juillet 2010(french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
17/08/2010 | Monthly communication regarding buyback programs | |
Continued Sales Growth in the second Quarter of 2010 Vétoquinol recorded strong sales growth (+15.1%) in the first six months of 2010, driven mainly by an increase in organic growth. |
16/07/2010 | Public releases | |
Programme de rachat - juin 2010(french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
08/07/2010 | Monthly communication regarding buyback programs | |
Bilan semestriel des moyens alloués au contrat de liquidité (2010) - french Au 30 juin 2010 : |
07/07/2010 | Liquidity contract | |
BOREVE-D: Vétoquinol is participating in a project to raise awareness of the need to treat pain in cattle June 30, 2010 (Lure, France) – Vétoquinol, in collaboration with two other veterinary laboratories, is participating in a project organised by the Syndicat de l’Industrie du Médicament Vétérinaire (SIMV) to raise awareness of the need to treat pain in cattle. |
30/06/2010 | Public releases | |
Procès Verbal des délibérations de l'Assemblée Générale Ordinaire du 7 mai 2010 (french) |
14/06/2010 | Shareholders´s Meeting | |
Monthly information regarding the total number of voting rights and shares making of the share capital - May 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
04/06/2010 | Voting rights | |
Programme de rachat - mai 2010(french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
04/06/2010 | Monthly communication regarding buyback programs | |
Monthly information regarding the total number of voting rights and shares making of the share capital - April 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
18/05/2010 | Voting rights | |
Programme de rachat - avril 2010(french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
18/05/2010 | Monthly communication regarding buyback programs | |
Vétoquinol - Assemblée Générale Ordinaire - 7 mai 2010 (french) <br>Faits marquants 2009 |
18/05/2010 | Shareholders´s Meeting | |
Résultat du scrutin de l'Assemblée générale du 7 mai 2010 (french) Résultats du scrutin |
18/05/2010 | Shareholders´s Meeting | |
Descriptif du programme de rachat d’actions propres soumis à l’assemblée générale ordinaire du 7 mai 2010 (french) Établi en application des dispositions des articles 241-1 et suivant du règlement général de l’Autorité des marchés financiers, le présent descriptif de programme de rachat d’actions propres a pour objet de décrire les finalités et les modalités du programme de rachat d’actions soumis à l’assemblée générale à caractère ordinaire du 7 mai 2010. |
30/04/2010 | Description of buyback programs | |
Vetoquinol publishes its registration document and its annual financial report relative to fiscal year 2009 (french version) The registration document of Vétoquinol relative to fiscal year 2009, including the annual financial report relative to fiscal year 2009, was registered with the Autorité des marchés financiers (“the AMF”) on April 22th, 2010. |
23/04/2010 | Public releases | |
Reference Document 2009 Reference Document 2009 |
23/04/2010 | Reference document | |
Continued sales growth driven by sustained organic growth April 22, 2010 (Lure, France) - Vétoquinol recorded a significant increase in sales in the first quarter of 2010, driven by sustained organic growth and the contribution of its Indian acquisition. |
22/04/2010 | Public releases | |
2009 activity report |
21/04/2010 | Annual Report | |
Monthly information regarding the total number of voting rights and shares making of the share capital - March 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
16/04/2010 | Voting rights | |
Programme de rachat - mars 2010(french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
16/04/2010 | Monthly communication regarding buyback programs | |
Departure of Pierre Konareff April 14, 2010 (Lure, France) – The Vétoquinol Group today announces the departure of Pierre |
14/04/2010 | Public releases | |
2009 Annual earnings 2009 Annual earnings |
01/04/2010 | Annual Report | |
2009 annual earnings March 31, 2010 – (Lure, France) – Vétoquinol’s Board of Directors, meeting on March 11, 2010, reviewed the Group’s business and approved its 2009 financial statements. |
31/03/2010 | Public releases | |
CONVOCATION : assemblée d'actionnaires et de porteurs de parts Avis de réunion valant avis de convocation. <br> |
30/03/2010 | Shareholders´s Meeting | |
Assemblée Générale Ordinaire du 7 mai 2010 : texte des résolutions PREMIERE RESOLUTION : Approbation des comptes sociaux de l’exercice 2009 |
30/03/2010 | Shareholders´s Meeting | |
Monthly information regarding the total number of voting rights and shares making of the share capital - February2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
05/03/2010 | Voting rights | |
Programme de rachat - février 2010(french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
05/03/2010 | Monthly communication regarding buyback programs | |
Redemption of tranche A bonds February 26, 2010 (Lure, France) - Following the decision of Soparfin (family holding Etienne Frechin) not to convert the tranche A convertible bonds when they reach maturity on February 27, 2010, Vétoquinol has redeemed the bonds. |
26/02/2010 | Public releases | |
Déclaration dirigeants SOPARFIN Déclaration individuelle relative aux opérations des personnes |
26/02/2010 | Monthly communication regarding buyback programs | |
Monthly information regarding the total number of voting rights and shares making of the share capital - January 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
05/02/2010 | Voting rights | |
Programme de rachat - janvier 2010(french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
05/02/2010 | Monthly communication regarding buyback programs | |
Strong growth in 2009 Revenues: +7.6% January 20, 2010 (Lure, France) - Vétoquinol recorded strong sales growth in 2009, despite an unfavourable exchange rate effect. The strength in sales is explained to a large extent by the contribution of acquisitions in Italy and India and by the resumption of organic growth, which held firm in the second half of 2009 despite the continuing weakness in the general economy. Revenues increased in all therapeutic classes and all geographic regions. |
20/01/2010 | Public releases | |
VÉTOQUINOL and JANSSEN ANIMAL HEALTH finalize an agreement for the exclusive distribution of SUROLAN® in the United States January 14, 2010 (Lure, France) – As part of its strategy of expanding its sales in the American market, Vétoquinol is pleased to announce an agreement with Janssen Animal Health to distribute Surolan® in the United States, following its approval by the FDA in December 2009. Surolan® is a leading example of Vétoquinol’s strategic focus on anti-infective agents and its success in this area. Surolan® has an excellent reputation in Europe, where it has been a great success. |
14/01/2010 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
11/01/2010 | Voting rights | |
Programme de rachat - décembre 2009 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
11/01/2010 | Monthly communication regarding buyback programs | |
Bilan semestriel des moyens alloués au contrat de liquidité (2009) - french Au 31 décembre 2009 |
05/01/2010 | Liquidity contract |